Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study

被引:35
|
作者
Gold, Michael S. [1 ]
Gidudu, Jane [2 ]
Erlewyn-Lajeunesse, Mich [3 ]
Law, Barbara [4 ]
机构
[1] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Southampton Univ Hosp NHS Trust, Southampton, Hants, England
[4] Publ Hlth Agcy Canada, Sci Sect, Immunizat & Resp Infect Div, Ottawa, ON, Canada
关键词
Brighton Collaboration anaphylaxis case definition; Checklists; Immunization safety; Case study; SAFETY DATA; GUIDELINES; COLLECTION;
D O I
10.1016/j.vaccine.2010.04.041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Brighton Collaboration (BC) was established in 2000 with the aim of developing globally accepted standardized case definitions for adverse events following immunizations (AEFI) as well as guidelines for the collection, analysis and presentation of surveillance data. Some of the BC case definitions are complex and this may limit their application for use in post-marketing vaccine surveillance. Barriers to the application of the BC case definitions include an incomplete description of an adverse event and inconsistencies in reporter use of adverse event terms. We have taken the BC case definition for anaphylaxis and developed a clinical checklist and glossary of terms used in the case definition. It is anticipated that these resources can be used at a community level by AEFI reporters. If used, these resources could improve the quality of adverse event reports which would facilitate the application of the BC case definition at a regional and/or national level. (C) 2010 Published by Elsevier Ltd.
引用
收藏
页码:4487 / 4498
页数:12
相关论文
共 50 条
  • [21] Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
    Bonhoeffer, J
    Menkes, J
    Gold, MS
    de Souza-Brito, G
    Fisher, MC
    Halsey, N
    Vermeer, P
    VACCINE, 2004, 22 (5-6) : 557 - 562
  • [22] The Role of Media and the Internet on Vaccine Adverse Event Reporting: A Case Study of Human Papillomavirus Vaccination
    Eberth, Jan M.
    Kline, Kimberly N.
    Moskowitz, David A.
    Montealegre, Jane R.
    Scheurer, Michael E.
    JOURNAL OF ADOLESCENT HEALTH, 2014, 54 (03) : 289 - 295
  • [23] Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study (vol 22, 741, 2022)
    Omoleke, Semeeh Akinwale
    Getachew, Biniam
    Isyaku, Abubakar
    Aliyu, Abdulrasheed Bello
    Mustapha, Ashiru Mohammed
    Dansanda, Shafiu Muhammad
    Kanmodi, Kehinde Kazeem
    Abubakar, Hafsat
    Lawal, Zahraddeen Ibrahim
    Kangiwa, Haruna Abdullahi
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [24] A case-control study of serious autoimmune adverse events following hepatitis B immunization
    Geier, DA
    Geier, MR
    AUTOIMMUNITY, 2005, 38 (04) : 295 - 301
  • [25] Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation
    Bines, JE
    Kohl, KS
    Forster, J
    Zanardi, LR
    Davis, RL
    Hansen, J
    Murphy, TM
    Music, S
    Niu, M
    Varricchio, F
    Vermeer, P
    Wong, EJC
    VACCINE, 2004, 22 (5-6) : 569 - 574
  • [26] Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: A case report and review of literature
    Manzo, Ciro
    Natale, Maria
    Castagna, Alberto
    AGING MEDICINE, 2021, 4 (03) : 234 - 238
  • [27] Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
    Bonhoeffer, J
    Vermeer, P
    Halperin, S
    Kempe, A
    Music, S
    Shindman, J
    Walop, W
    VACCINE, 2004, 22 (5-6) : 586 - 591
  • [28] No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase
    Carnovale, Carla
    Raschi, Emanuel
    Leonardi, Luca
    Moretti, Ugo
    De Ponti, Fabrizio
    Gentili, Marta
    Pozzi, Marco
    Clementi, Emilio
    Poluzzi, Elisabetta
    Radice, Sonia
    EXPERT REVIEW OF VACCINES, 2018, 17 (04) : 363 - 381
  • [29] Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy
    Scavone, Cristina
    Rafaniello, Concetta
    Brusco, Simona
    Bertini, Michele
    Menditto, Enrica
    Orlando, Valentina
    Trama, Ugo
    Sportiello, Liberata
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [30] Continuous quality improvement methodology: a case study on multidisciplinary collaboration to improve chlamydia screening
    Ursu, Allison
    Greenberg, Grant
    McKee, Michael
    FAMILY MEDICINE AND COMMUNITY HEALTH, 2019, 7 (02)